Clinical Trial Update: CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision [Phase 2]

View source ↗

Summary

Phase 2 trial update for a regimen combining capecitabine, oxaliplatin, radiotherapy, and surgical excision in rectal cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Rectal Neoplasms | Phase 2 | Status: COMPLETED